STYLE SHEET
GLOBAL CSS
COLORS
ANIMATIONS
MEDIA QUERY
SPACING SYSTEM

Henrik Lundvall

Head of content

Henrik has extensive experience in senior roles within international media and tech companies, including TT, Expressen, Microsoft, Axel Springer and Lifesum. At Yazen, he is Head of Content, with responsibility for strategy, marketing and in-app content, working closely with product, medical and tech teams.

LinkedIn logo
Portrait imageOrange stylized human head with colorful flowers and vines growing out from the top and back.

Henrik Lundvall has a solid background in leadership roles across international digital media and tech companies. He started his career in local media in Sweden and has since held senior roles at TT, Expressen and Microsoft, where he worked as Operations Lead. Within the Axel Springer group, he was responsible for launching the company’s products across 28 international markets, and he has also been Managing Editor at Lifesum.

At Yazen, Henrik is Head of Content. He’s responsible for everything related to content across the business – from content and communications strategy to marketing, in-app content and business development. In his role, he leads cross-functional teams and works closely with product, doctors and tech teams to make sure the content is evidence-based, engaging and genuinely useful for the people using Yazen.

Articles by

Henrik Lundvall

Melatonin for weight loss? What does the research say?

Melatonin is the active ingredient in medicines such as Circadin and Melatonin Neurim. These medicines are used for short-term treatment of primary insomnia, where sleep quality is poor. But how could this affect your weight?

Myths and facts about obesity

There are many myths and prejudices surrounding overweight and obesity. They are deeply rooted in society and can create guilt, shame and misunderstanding, despite obesity being a complex medical condition influenced by biology, environment and living conditions. When myths dominate the conversation, they obscure what actually helps. In this article, we address common misconceptions and highlight knowledge that truly makes a difference.

Body mass index (BMI), body measurements and body composition – why Yazen uses multiple measures

Body mass index (BMI) is a commonly used measure of the relationship between weight and height in weight loss and obesity treatment, but it does not provide the full picture of your health. At Yazen, we therefore complement BMI with body measurements and body composition to gain a better understanding of your body and develop more individualised strategies for sustainable weight loss.

Mysimba: Weight treatment in tablet form

Mysimba is a prescription medication in tablet form used for the treatment of overweight and obesity. It contains the active substances naltrexone and bupropion, which together affect the brain's appetite and reward systems.

Lose weight with tablets – medical weight loss without injections

According to the WHO, overweight and obesity affect nearly 60 per cent of the adult population in Europe, highlighting the need for integrated treatment strategies that combine medical therapy with lifestyle changes (1).

Beyond GLP-1 medicines: the path to successful and long-term weight loss

We are in a new era of obesity treatment. GLP-1-based medicines have transformed the landscape – but real success is achieved when medication becomes part of a comprehensive approach that supports the whole person.

Long-term health and weight loss require more than medicine alone. It is when medical treatment is combined with lifestyle change and continuous guidance that meaningful, lasting progress becomes possible (1–2).

Trulicity and Medical Weight Loss: How Treatment with Dulaglutide Works

Trulicity is a prescription medication containing the active substance dulaglutide. It belongs to the group of GLP-1 receptor agonists and is used for the treatment of type 2 diabetes.

Dulaglutide mimics the effect of the body's own hormone GLP-1, which helps regulate blood sugar. The medication can also affect appetite and satiety, which can lead to some weight loss.

Saxenda (liraglutide) in the Treatment of Obesity

Saxenda is a daily injection treatment with liraglutide that can reduce appetite and increase the feeling of fullness. It is used for overweight and obesity, combined with diet and exercise. The dosage is stepped up gradually to reduce side effects such as nausea.

How to reduce the risk of loose skin after weight loss

Weight loss can bring significant positive changes for both health and wellbeing. At the same time, many people experience loose skin after substantial weight loss, especially if the weight has decreased rapidly or if they have lived with overweight or obesity for a long time.

Loose skin is a natural result of changes in the skin’s elasticity as the body adjusts. By understanding how the skin is affected after weight loss and which factors influence its elasticity, you can give the skin better conditions to tighten and feel firmer again.